
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN: ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.
moreShow ASLN Financials
Recent trades of ASLN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ASLN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ASLN's company Twitter account
Number of mentions of ASLN in WallStreetBets Daily Discussion
Recent insights relating to ASLN
Recent picks made for ASLN stock on CNBC
ETFs with the largest estimated holdings in ASLN
Flights by private jets registered to ASLN